Keyi Wang
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Biological Psychiatry top 5%
Papers in
-
- Glycosylation and Glycoproteins Research 15
- RNA modifications and cancer 11
- Co-authors
- Weipu Mao (36 shared papers)Bo Peng (31 shared papers)Qijin Zhang (14 shared papers)Yuguang Du (9 shared papers)Martin C. Hawley (2 shared papers)Jun Niu (3 shared papers)Lennart Iselius (1 shared paper)Ya‐Qing Lou (1 shared paper)
- Journals
- Electrophoresis (7 papers)Clinica Chimica Acta (6 papers)International Immunopharmacology (4 papers)The Science of The Total Environment (4 papers)Frontiers in Oncology (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Keyi Wang
270 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 174
- Pharmacology 277
- Biological Psychiatry 67
- Cancer Research 367
- Molecular Biology 1.3k
- Media Technology 135
Countries citing papers authored by Keyi Wang
This map shows the geographic impact of Keyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyi Wang more than expected).
Fields of papers citing papers by Keyi Wang
This network shows the impact of papers produced by Keyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyi Wang. The network helps show where Keyi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Keyi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 291 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 343 | |
| 2 | 2016 | 116 | |
| 3 | 2017 | 108 | |
| 4 | 2018 | 99 | |
| 5 | 1995 | 97 | |
| 6 | 2023 | 94 | |
| 7 | 2020 | 94 | |
| 8 | 2012 | 78 | |
| 9 | 2013 | 75 | |
| 10 | 2004 | 75 | |
| 11 | 2019 | 72 | |
| 12 | 2021 | 68 | |
| 13 | 2010 | 68 | |
| 14 | 2018 | 65 | |
| 15 | 2020 | 62 | |
| 16 | 2019 | 56 | |
| 17 | 2006 | 51 | |
| 18 | Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. | 1998 | 49 |
| 19 | 2021 | 47 | |
| 20 | 2020 | 46 |
About Keyi Wang
Keyi Wang is a scholar working on Molecular Biology, Biomedical Engineering, Pulmonary and Respiratory Medicine, Materials Chemistry and Oncology, having authored 291 papers that have together received 4.5k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (15 papers), Optical measurement and interference techniques (15 papers), Liquid Crystal Research Advancements (11 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers), RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (10 papers), Advanced Vision and Imaging (10 papers) and Fungal Infections and Studies (9 papers). The work is most often cited by research in Pharmacology (277 citations), Biological Psychiatry (67 citations), Cancer Research (367 citations), Molecular Biology (1.3k citations) and Media Technology (135 citations). Keyi Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Weipu Mao, Bo Peng, Qijin Zhang, Yuguang Du, Martin C. Hawley, Jun Niu, Lennart Iselius, Ya‐Qing Lou, Amariliz Rivera and Leif Bertilsson. Their work appears in journals such as Electrophoresis, Clinica Chimica Acta, International Immunopharmacology, The Science of The Total Environment and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.